She joined the Cockrell School of Engineering in Spring 2013 from Harvard University's Wyss Institute for Biologically Inspired Engineering, where she helped integrate computational and experimental approaches to identify and validate novel gene targets for the normalization of breast cancer by differentiation therapy.